Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael G Dodds

Showing results (1-10 of 16) with videos related to

Pageof 2
Sort By:
Annals of Biomedical Engineering|October 21, 2004
Assessing convergence of Markov chain Monte Carlo simulations in hierarchical Bayesian models for population pharmacokineticsMichael G Dodds, Paolo Vicini
The AAPS Journal|December 16, 2005
Population pharmacokinetics of recombinant factor XIII in cynomolgus monkeysMichael G Dodds, Jennifer E Visich, Paolo Vicini
British Journal of Clinical Pharmacology|July 28, 2021
COVID-19 acute respiratory distress syndrome: A simulation study of the effects of combination therapy with tocilizumab and siltuximabEileen B Doyle, Darren Bentley, Michael G Dodds
Journal of Pharmacokinetics and Pharmacodynamics|October 6, 2005
Robust population pharmacokinetic experiment designMichael G Dodds, Andrew C Hooker, Paolo Vicini
British Journal of Clinical Pharmacology|July 22, 2020
Model-informed drug repurposing: Viral kinetic modelling to prioritize rational drug combinations for COVID-19Michael G Dodds, Rajesh Krishna, Antonio Goncalves, et al.
Annals of Biomedical Engineering|February 8, 2003
An evaluation of population D-optimal designs via pharmacokinetic simulationsAndrew C Hooker, Marco Foracchia, Michael G Dodds, et al.
American Journal of Physiology. Endocrinology and Metabolism|January 6, 2005
Integrated model of hepatic and peripheral glucose regulation for estimation of endogenous glucose production during the hot IVGTTKevin M Krudys, Michael G Dodds, Stephanie M Nissen, et al.
Mabs|May 20, 2014
A model-based meta-analysis of monoclonal antibody pharmacokinetics to guide optimal first-in-human study designJasmine P Davda, Michael G Dodds, Megan A Gibbs, et al.
The Lancet. Global Health|February 18, 2022
Fluvoxamine for the treatment of COVID-19Michael G Dodds, Eileen B Doyle, Angela M Reiersen, et al.
Cancer Immunology, Immunotherapy : CII|October 18, 2008
Immune activation in advanced cancer patients treated with recombinant IL-21: multianalyte profiling of serum proteinsMichael G Dodds, Klaus Stensgaard Frederiksen, Kresten Skak, et al.
Pageof 2

Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
Annals of Biomedical Engineering|October 21, 2004
Assessing convergence of Markov chain Monte Carlo simulations in hierarchical Bayesian models for population pharmacokineticsMichael G Dodds, Paolo Vicini
The AAPS Journal|December 16, 2005
Population pharmacokinetics of recombinant factor XIII in cynomolgus monkeysMichael G Dodds, Jennifer E Visich, Paolo Vicini
British Journal of Clinical Pharmacology|July 28, 2021
COVID-19 acute respiratory distress syndrome: A simulation study of the effects of combination therapy with tocilizumab and siltuximabEileen B Doyle, Darren Bentley, Michael G Dodds
Journal of Pharmacokinetics and Pharmacodynamics|October 6, 2005
Robust population pharmacokinetic experiment designMichael G Dodds, Andrew C Hooker, Paolo Vicini
British Journal of Clinical Pharmacology|July 22, 2020
Model-informed drug repurposing: Viral kinetic modelling to prioritize rational drug combinations for COVID-19Michael G Dodds, Rajesh Krishna, Antonio Goncalves, et al.
Annals of Biomedical Engineering|February 8, 2003
An evaluation of population D-optimal designs via pharmacokinetic simulationsAndrew C Hooker, Marco Foracchia, Michael G Dodds, et al.
American Journal of Physiology. Endocrinology and Metabolism|January 6, 2005
Integrated model of hepatic and peripheral glucose regulation for estimation of endogenous glucose production during the hot IVGTTKevin M Krudys, Michael G Dodds, Stephanie M Nissen, et al.
Mabs|May 20, 2014
A model-based meta-analysis of monoclonal antibody pharmacokinetics to guide optimal first-in-human study designJasmine P Davda, Michael G Dodds, Megan A Gibbs, et al.
The Lancet. Global Health|February 18, 2022
Fluvoxamine for the treatment of COVID-19Michael G Dodds, Eileen B Doyle, Angela M Reiersen, et al.
Cancer Immunology, Immunotherapy : CII|October 18, 2008
Immune activation in advanced cancer patients treated with recombinant IL-21: multianalyte profiling of serum proteinsMichael G Dodds, Klaus Stensgaard Frederiksen, Kresten Skak, et al.
Pageof 2